Cara's Therapeutics oral difelikefalin as adjunct therapy to TCS did not demonstrate a meaningful clinical benefit compared to TCS alone. Among CARA's 3 late-stage programs, investors perhaps had the ...

Cara Therapeutics Inc (NASDAQ:CARA) is trading higher Tuesday after the company, and Vifor Pharma, announced the U.S. Food and Drug Administration approved KORSUVA for injection for the treatment of ...

(RTTNews) - Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on pruritus treatments, has announced the effective date of a 1-for-12 reverse stock split. Cara's common stock begined ...

The reverse stock split aims to help Cara Therapeutics regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Following the reverse stock split, ...

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.